-
941
Transmission dynamics and control for a brucellosis model in Hinggan League of Inner Mongolia, China
Published 2014-05-01Subjects: Get full text
Article -
942
Etiology and epizootology of bovine mastitis (analytical review)
Published 2024-03-01Subjects: Get full text
Article -
943
Profile and Geospatial Analysis of Dog Bite Cases Attending the Antirabies Vaccine Outpatient Department at the Tertiary Level Hospital of Mumbai
Published 2024-04-01Subjects: “…antirabies vaccination…”
Get full text
Article -
944
Evaluation of tick salivary and midgut extracellular vesicles as anti-tick vaccines in White-tailed deer (Odocoileus virginianus)
Published 2025-01-01Subjects: Get full text
Article -
945
-
946
Assessing the impact of educational methods on influenza vaccine uptake and patient knowledge and attitudes: a randomised controlled trial
Published 2023-02-01Subjects: Get full text
Article -
947
-
948
Accessibility of COVID-19 Vaccines in African Countries: A System Dynamics Model Examining Income, Logistics, and Governance
Published 2024-12-01Subjects: Get full text
Article -
949
Evaluation of Immune Characteristics and Factors Associated with Immune Response following Hepatitis B Vaccination among Ghanaian Adolescents
Published 2024-01-01“…WHO recommends HBV-negative babies in high-prevalence (8%) countries receive anti-HBV vaccination. Ghana initiated mass immunization in 2002, but concerns remain about vaccine effectiveness and long-term protection. …”
Get full text
Article -
950
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination
Published 2022-01-01“…Samples were collected from 42 SARS-CoV-2 infected patients during the first pandemic wave, 50 subjects who received 2 doses of mRNA vaccine before the Omicron wave, 44 subjects who received 3 doses of mRNA vaccine, and 35 subjects who received heterologous vaccination (2 doses of adenovirus-based vaccine plus mRNA vaccine) during the Omicron wave. …”
Get full text
Article -
951
N-Terminal Plasmodium vivax Merozoite Surface Protein-1, a Potential Subunit for Malaria Vivax Vaccine
Published 2013-01-01“…The lack of in vitro cultures for P. vivax represents a major delay in developing a functional malaria vaccine. One of the major candidates to antimalarial vaccine is the merozoite surface protein-1 (MSP1), which is expressed abundantly on the merozoite surface and capable of activating the host protective immunity. …”
Get full text
Article -
952
The Adoption Process to Technology Biosecurity and Vaccination in the Dispersal of Foot and Mouth Disease Bone Regency, South Sulawesi Province
Published 2025-01-01“… Adopting biosecurity and vaccination technology is one of the steps that can be taken to overcome and minimize FMD disease in beef cattle farming. …”
Get full text
Article -
953
Ecological study of the association between the English national vaccination programme and area deprivation inequalities in COVID-19 mortality
Published 2025-01-01“…However, more could be achieved if barriers to vaccination uptake in the most deprived areas are overcome.…”
Get full text
Article -
954
The immunogenicity of PRV ΔgE/TK/UL49.5 three-gene-deleted vaccine in mice
Published 2025-02-01“…Abstract Background Pseudorabies (PR) caused by the re-emerging of pseudorabies virus (PRV) variant has outbroken among PRV vaccine immunized swine in many pig farms, which has caused serious social and economic consequences since the end of 2011. …”
Get full text
Article -
955
Adverse Events of the BCG (Bacillus Calmette–Guérin) and Rotavirus Vaccines in a Young Infant with Inborn Error of Immunity
Published 2020-01-01“…The Bacillus Calmette–Guérin (BCG) and rotavirus vaccines are live-attenuated preparations. In the United Arab Emirates, these products are universally administered to the young infants. …”
Get full text
Article -
956
Corrigendum: A self-assembled nanoparticle vaccine elicits effective neutralizing antibody response against EBV infection
Published 2025-02-01Subjects: Get full text
Article -
957
A Case Report of DVT following the Johnson and Johnson Vaccine against the Novel SARS-CoV-2
Published 2022-01-01“…In this case report, we present a female who developed a DVT four days after receiving the J&J vaccine. We propose that the administration of this vaccine may further increase the risk of developing DVTs in patients with previous risk factors, and we hope to use this case to support screening all patients for previous risk factors for thrombosis before administration of the J&J vaccine.…”
Get full text
Article -
958
Vaccination ARN messager (ARNm), modèle de transition de la biologie fondamentale à la médecine
Published 2024-01-01Subjects: Get full text
Article -
959
Prevalence of COVID-19 Vaccine Hesitancy Among Healthcare Workers in Nigeria: A Systematic Review and Meta-Analysis
Published 2025-02-01Subjects: Get full text
Article -
960
Association between leukocyte telomere length and specific antibody levels after vaccination against tick-borne encephalitis
Published 2020-01-01Subjects: Get full text
Article